跳至主要内容
临床试验/NL-OMON56667
NL-OMON56667尚未招募不适用

FeAsibility of a PReoperative, multimodal lifestyle InterventiOn in patients with breast cancer ReceivIng neoadjuvant chemotherapy (APRIORI-study) - APRIORI-study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients diagnosed with stage I-III breast cancer eligible for neoadjuvant
  • intravenous chemotherapy at the Maastricht University Medical Center
  • Aged >=18 years
  • Eastern Cooperative Oncology Group (ECOG) Performance Status Scale
  • grade 0-1 (Table 1) [40,41]
  • Enough understanding of the Dutch language

排除标准

  • Human Epidermal growth factor Receptor 2 (HER2) - positive tumour
  • Scalp cooling
  • Recurrent breast cancer
  • Conditions that seriously hamper physical exercise
  • Incapacitated subjects as reported by the attending medical specialist in the
  • medical record. When any doubt arises, the patient will not be considered

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验